+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 120Years
MALE
ID05155046

Evaluating 18F-DCFPyL PETCT Imaging to Assess Treatment Response in Localized Prostate Cancer Receiving Stereotactic Body Radiation Therapy

Led by National Cancer Institute (NCI) · Updated on 2026-10-16

130

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how an imaging agent called 18F-DCFPyL can detect how well patients with localized prostate cancer respond to standard treatments like stereotactic body radiation therapy SBRT with or without androgen deprivation therapy ADT. The purpose is to see if this imaging method can identify disease persistence or recurrence earlier than current methods, which could allow for more effective treatments. This research focuses on men 18 years and older with newly diagnosed prostate cancer without distant metastases. Participants will receive SBRT with or without ADT as their treatment. Imaging with 18F-DCFPyL PETCT scans and multiparametric MRI mpMRI will be done at baseline, 8 weeks after starting ADT if applicable, 6 months after completing SBRT, and at any recurrence. The imaging involves an IV injection of the tracer and scans lasting 45 minutes to 1 hour. The study includes cohorts receiving different combinations of radiation and ADT to assess imaging response. During the study, participants will undergo medical history reviews, physical exams, blood and urine tests, and complete quality of life questionnaires. Follow-up visits will occur 1 month after treatment, then every 3 months for a year, and every 6 months for another year to monitor outcomes. Researchers will measure imaging response over time and track biochemical control and quality of life for up to 2 years after treatment completion.

CONDITIONS

Brief Title

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Research Team

D

Debbie-Ann N Nathan, R.N.

D

Deborah E Citrin, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here